Patents by Inventor Michael Hunter Welch

Michael Hunter Welch has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of preparing AZA-pyridone compounds
    Patent number: 10183945
    Abstract: Disclosed herein are methods for obtaining aza-pyridone compounds, which can be useful for ameliorating and/or treating a disease and/or a condition, including an orthomyxovirus infection.
    Type: Grant
    Filed: March 10, 2017
    Date of Patent: January 22, 2019
    Assignee: ALIOS BIOPHARMA, INC.
    Inventors: Michael Hunter Welch, Leonid Beigelman, Robert Than Hendricks, Andras Horvath, Gareth Brown, Prasad Ganji, Stefan Mix
  • METHOD OF PREPARING AZA-PYRIDONE COMPOUNDS
    Publication number: 20170260189
    Abstract: Disclosed herein are methods for obtaining aza-pyridone compounds, which can be useful for ameliorating and/or treating a disease and/or a condition, including an orthomyxovirus infection.
    Type: Application
    Filed: March 10, 2017
    Publication date: September 14, 2017
    Inventors: Michael Hunter WELCH, Leonid BEIGELMAN, Robert Than HENDRICKS, Andras HORVATH, Gareth BROWN, Prasad GANJI, Stefan MIX
  • Substituted nucleosides, nucleotides and analogs thereof
    Patent number: 9598457
    Abstract: Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HCV infection with one or more nucleotide analogs.
    Type: Grant
    Filed: December 19, 2013
    Date of Patent: March 21, 2017
    Assignee: Alios BioPharma, Inc.
    Inventors: David Bernard Smith, Leonid Beigelman, Guangyi Wang, Michael Hunter Welch
  • SUBSTITUTED NUCLEOSIDES, NUCLEOTIDES AND ANALOGS THEREOF
    Publication number: 20160039861
    Abstract: Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a HCV infection with one or more nucleotide analogs.
    Type: Application
    Filed: December 19, 2013
    Publication date: February 11, 2016
    Applicant: ALIOS BIOPHARMA, INC.
    Inventors: David Bernard Smith, Leonid Beigelman, Guangyi Wang, Michael Hunter Welch